Cargando…
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
Colorectal cancer (CRC) is a major cause of cancer-related death in the world. Emerging evidence suggests that the clinical success of conventional chemotherapy does not merely rely on cell toxicity, but also results from the restoration of tumor immune surveillance. Anti-tumor immune response can b...
Autores principales: | Di Grazia, Antonio, Laudisi, Federica, Di Fusco, Davide, Franzè, Eleonora, Ortenzi, Angela, Monteleone, Ivan, Monteleone, Giovanni, Stolfi, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281008/ https://www.ncbi.nlm.nih.gov/pubmed/32455811 http://dx.doi.org/10.3390/cancers12051314 |
Ejemplares similares
-
OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021) -
Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019) -
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease
por: Di Grazia, Antonio, et al.
Publicado: (2022) -
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis
por: Di Grazia, Antonio, et al.
Publicado: (2020) -
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)